Upgrade to SI Premium - Free Trial

UPDATE: Baird Downgrades Vir Biotechnology (VIR) to Underperform

February 27, 2020 4:37 AM
(Updated - February 27, 2020 8:14 AM EST)

(updating comment)Baird analyst Madhu Kumar downgraded Vir Biotechnology (NASDAQ: VIR) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades

Next Articles